Vernalis PLC | Balance Sheet

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
76,940.00
70,750.00
61,559.00
84,018.00
61,258.00
Total Accounts Receivable
5,175.00
5,621.00
6,367.00
6,508.00
7,942.00
Inventories
130.00
130.00
-
233.00
933.00
Other Current Assets
1,053.00
-
4,117.00
2,413.00
304.00
Total Current Assets
83,298.00
76,501.00
72,043.00
93,172.00
70,437.00
Net Property, Plant & Equipment
1,438.00
1,625.00
1,637.00
1,673.00
1,409.00
Intangible Assets
6,292.00
10,940.00
12,895.00
17,645.00
21,626.00
Total Assets
91,028.00
89,066.00
86,575.00
112,490.00
94,168.00
Accounts Payable
744.00
2,625.00
476.00
511.00
961.00
Income Tax Payable
-
15.00
5.00
80.00
64.00
Other Current Liabilities
3,757.00
2,483.00
4,734.00
7,120.00
8,650.00
Total Current Liabilities
4,501.00
5,123.00
5,215.00
7,711.00
9,675.00
Provision for Risks & Charges
4,127.00
3,404.00
3,510.00
504.00
394.00
Deferred Taxes
-
-
-
-
696.00
Other Liabilities
156.00
360.00
744.00
1,544.00
1,323.00
Total Liabilities
8,784.00
8,887.00
9,469.00
9,759.00
11,392.00
Common Equity (Total)
82,244.00
80,179.00
77,106.00
102,731.00
82,776.00
Total Shareholders' Equity
82,244.00
80,179.00
77,106.00
102,731.00
82,776.00
Total Equity
82,244.00
80,179.00
77,106.00
102,731.00
82,776.00
Liabilities & Shareholders' Equity
91,028.00
89,066.00
86,575.00
112,490.00
94,168.00

About Vernalis

View Profile
Address
100 Berkshire Place
Winnersh Berkshire RG41 5RD
United Kingdom
Employees -
Website http://vernalis.com
Updated 09/14/2018
Vernalis Plc is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U. S.